Business Wire

10x1000 Tech for Inclusion Demonstrates Impact of AI-Driven Entrepreneurship in Emerging Markets at 2025 Inclusion Conference

22.9.2025 09:58:00 CEST | Business Wire | Press Release

Share

As artificial intelligence (AI) reshapes industries worldwide, it brings both unprecedented opportunities and pressing challenges, such as widening digital divides and developmental gaps. At the 2025 Inclusion Conference on the Bund in Shanghai, 10x1000 Tech for Inclusion spotlighted how AI-driven entrepreneurship is creating impact in emerging markets.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250921082321/en/

At the 2025 Inclusion conference, tech pioneers from emerging markets shared the insights to the power of AI-driven entrepreneurship.

Launched by Ant Group in partnership with the International Finance Corporation (IFC), 10x1000 Tech for Inclusion is a global, non-profit learning platform dedicated to empowering the next generation of digital economy leaders. Built on the three key pillars of Learn, Connect, Inspire, the initiative equips entrepreneurs with the skills, networks, and insights needed to create sustainable, tech-driven solutions for inclusion.

"AI can be transformative, but it continues to evolve at an unprecedented pace and nobody has all the answers – organizations are simultaneously experimenting and learning. For startups, it becomes even more crucial that they look beyond their borders to learn from the best practices globally and apply that to address their unique local needs," said Di XU, product leader of sustainability initiatives at Ant International. "International exchanges for startups are not just about growth, they are key to sustainable and inclusive development. The 10×1000 Tech for Inclusion platform facilitates the global exchange of ideas and empowers emerging leaders to transform global insights into locally relevant solutions, driving truly sustainable and inclusive growth.”

Bridging Borders, Building Futures

The panel discussion, "AI-Powered Entrepreneurship: Catalyzing Local Impact in Emerging Markets", brought together founders from Asia, Africa, and beyond. Their stories underscored 10x1000's mission: to transform a global learning community into a springboard for innovation, collaboration, and scalable impact. Key takeaways from their sharing include:

  • Innovation empowers equitable growth for SMEs: Khang Wei Wong, founder of Singapore and Malaysia's Fulhive & Smart Tradehub, shared how exposure to cutting-edge retail technology and global leaders is fuelling innovation and driving equitable growth for small and medium enterprises.

  • Technology can uplift every child, regardless of background: Dr. Low Hui Min, founder of Malaysian EdTech company LEMON©, said AI is pioneering new ways to detect learning difficulties in children, demonstrating technology's power to uplift every child—regardless of background.

  • Adaptability is Key to Tech-driven Market expansion: Sida Zheng, co-founder of global business platform Rosen, shared how an AI-powered credit assessment model could enable flexible workers in Latin America to access working capital, breaking traditional barriers faced by the unbanked populations in the region.

  • Global Collaboration Drives Expansion Strategy: Fifamè Ogou of Benin-based UrgenceCare demonstrated how adaptive AI routing systems could reduce emergency response times by learning from infrastructure limitations, significantly improving medical outcomes in resource-constrained environments.

  • AI is reshaping affordable healthcare for all: Dr. Ikpeme Neto, founder of Nigerian healthtech startup WellaHealth, highlighted that he was inspired by how an intelligent family doctor AI agent powered by natural language processing has served patients in remote areas, making quality healthcare guidance accessible even in regions with limited internet connectivity.

As demonstrated at the Inclusion Conference, by connecting emerging market entrepreneurs with global insights and resources, 10×1000 Tech for Inclusion is fostering a new generation of leaders who are redefining what it means to build inclusive, sustainable solutions.

"At 10×1000 Tech for Inclusion, we believe that true innovation thrives when knowledge crosses borders. When a Nigerian healthtech founder advises a Malaysian EdTech startup through our platform, that's how we build inclusive innovation ecosystems. We are not just facilitating a conversation, but laying the groundwork for tomorrow’s innovations. Today’s stage appearances are just the beginning of their global impact. What begins as knowledge exchange will soon become a powerful global network driving sustainable development for decades to come,” added Di Xu.

About 10x1000 Tech for Inclusion

10x1000 Tech for Inclusion is an open and global fintech learning platform dedicated to empowering learners to become drivers of digital economic growth. Its mission is to nurture and inspire at least 1,000 emerging talents and tech leaders each year for ten years. 10x1000 is a non-profit program launched jointly by the International Finance Corporation (IFC), a member of the World Bank Group, and Ant Group in 2018.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250921082321/en/

Contacts

Media Contact
Mail: info@10x1000.org
Learn more: 10x1000.org

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye